Impact of glycaemic status on the cardiac effects of empagliflozin when initiated immediately after myocardial infarction: A post‐hoc analysis of the <scp>EMMY</scp> trial-Reference-Cited by-同舟云学术

Impact of glycaemic status on the cardiac effects of empagliflozin when initiated immediately after myocardial infarction: A post‐hoc analysis of the EMMY trial

Published:2024-01-29 Issue: Volume: Page:
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obesity Metabolism

Author:

Sourij Caren¹,Oulhaj Abderrahim²,Aziz Faisal³⁴^ORCID,Tripolt Norbert J.³⁴^ORCID,Aberer Felix³⁴^ORCID,Pferschy Peter N.³⁴,Postula Marek⁵,Drexel H.⁶,Benedikt Martin¹,Kolesnik Ewald¹,Pieber Thomas R.⁴,Bugger Heiko¹,von Lewinski Dirk¹,Sourij Harald³⁴^ORCID

Affiliation:

1. Division of Cardiology Medical University of Graz Graz Austria

2. Department of Public Health and Epidemiology, College of Medicine and Health Sciences Khalifa University Abu Dhabi United Arab Emirates

3. Interdisciplinary Metabolic Medicine Trials Unit, Division of Endocrinology and Diabetology Medical University of Graz Graz Austria

4. Division of Endocrinology and Diabetology Medical University of Graz Graz Austria

5. Department of Experimental and Clinical Pharmacology Medical University of Warsaw Warsaw Poland

6. VIVIT Institute Feldkirch Austria

Funder

Boehringer Ingelheim

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference12 articles.

1. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

2. Evaluation of the effect of sodium–glucose co‐transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR‐Reduced trial

3. Empagliflozin in Heart Failure with a Preserved Ejection Fraction

4. Empagliflozin in acute myocardial infarction: the EMMY trial

5. Post-challenge hyperglycaemia is strongly associated with future macrovascular events and total mortality in angiographied coronary patients